Barlas Stephen
P T. 2018 Jan;43(1):31-39.
Is industry consolidation a response to President Donald Trump's repeated denunciation of high drug prices and congressional hearings on the issue? The author considers whether any of this corporate collaboration will get at some of the significant, underlying problems in the drug-pricing space.
行业整合是对唐纳德·特朗普总统多次谴责高药价以及国会就此问题举行听证会的回应吗?作者思考了这种企业间的合作是否会触及药品定价领域一些重大的潜在问题。